Sotera Health stock reports 9.2 percent revenue growth in Q2
Published on 09/25/2026 at 06:57 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Sotera Health stock (SHC) was trading at USD 18.45 on Nasdaq on September 24, 2026, up 0.87 percent for the session. The company reported Q2 2026 revenue of USD 321.375 million, an increase of 9.2 percent from the same quarter a year earlier.
Profit growth sharpens the story
According to Sotera Health, net income reached USD 54 million in Q2 2026, compared with USD 8 million in Q2 2025. Diluted earnings per share rose to USD 0.19 from USD 0.03 over the same period.
The operating result also improved to USD 106.792 million in Q2 2026 from USD 75.827 million in Q1 2026. That sequential increase shows why margin expansion matters alongside the company revenue trend.
Results cleared analyst expectations
Adjusted EPS came in at USD 0.26 for Q2 2026, above the USD 0.24 consensus estimate, while revenue of USD 321.38 million exceeded the USD 309.70 million forecast. Investing.com reported on September 8, 2026, that Piper Sandler reiterated its Overweight rating and USD 25.00 price target.
The comparison is material for investors because the quarterly revenue beat came alongside a 9.2 percent year over year increase, rather than relying on a single cost reduction. Sotera Health operates sterilization, laboratory testing and advisory businesses serving healthcare customers, giving revenue performance a direct link to recurring service demand.
Nasdaq price stays near yearly high
At USD 18.45 on September 24, 2026, Sotera Health had a market capitalization of USD 5,261,331,039. Its 52-week range was USD 13.09 to USD 19.85, placing the latest quote USD 1.40 below the yearly high.
The stock's market position now reflects both the Q2 earnings comparison and the higher operating result. The next valuation checkpoint is whether revenue growth and profitability continue together in the following quarterly report.
Sotera Health stock facts
- Company: Sotera Health Company
- Ticker: SHC
- Trading venue: Nasdaq
- Price as of September 24, 2026: USD 18.45
- Market capitalization: USD 5,261,331,039 as of September 24, 2026
- 52-week range: USD 13.09-19.85 as of September 24, 2026
- Sector / Industry: Healthcare / Medical Diagnostics and Research
